FDA Launches Expedited IND Pilot Program to Accelerate Human Trials, Raising IP Considerations for Sponsors
Key Takeaways: The Expedited Investigational New Drug (IND) Pilot Program is intended to evaluate whether leveraging qualified research institutions (QRIs) and a rolling review process can improve the efficiency of...
Knobbe Martens Partners Honored as 2027 IAM Global Leaders
IRVINE, Calif., October 23, 2026 – Knobbe Martens is pleased to share that partners Sabing Lee, Salima Merani, Ph.D., and Joseph Re have been featured in the 2027 IAM Global...
4th Annual MCLE-a-thon: Federal Funding & Legal Landmines: A Guide for In‑House Teams
As part of the firm’s 4th annual MCLE‑a‑thon, Lance D. Smemoe provides a practical overview of the intellectual property risks associated with federal funding and government contracts. Lance discusses how...